Founded in 2010, OrCam Technologies operates in assistive technology. Investors last valued the company at $1.5B. The stock is not listed on any public market.
One company valuation: $1.5B (post-money).
Intel CapitalLEADOrCam Technologies builds AI-powered wearable and handheld devices for people who are blind, have low vision, or face reading difficulties, best known for the OrCam MyEye, a small camera that clips onto eyeglasses and reads text, recognizes faces and identifies objects through audio feedback. Founded in Jerusalem in 2010 by Amnon Shashua and Ziv Aviram, who had previously built Mobileye, the company began selling MyEye commercially in 2015 and later added the handheld OrCam Read, named one of TIME's best inventions in 2019 and 2021.
Following layoffs in 2022-2024, OrCam discontinued its vision products and pivoted to hearing assistive technology under the OrCam Hear brand, with employee count falling below 50 by 2025.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds OrCam Technologies.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. OrCam Technologies availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — OrCam Technologies included.
Lead investors for each round are in the funding timeline.
The closest assistive technology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. OrCam Technologies is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
